Umberto Benedetto1, Shahzad G Raja2, Alberto Albanese2, Mohammed Amrani2, Giuseppe Biondi-Zoccai3, Giacomo Frati4. 1. Department of Cardiac Surgery, Harefield Hospital, London, UK umberto.benedetto@hotmail.com. 2. Department of Cardiac Surgery, Harefield Hospital, London, UK. 3. Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Rome, Italy. 4. Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Rome, Italy Department of AngioCardio Neurology, IRCCS NeuroMed, Pozzilli, Italy.
Abstract
OBJECTIVES: There is a lack of unequivocal evidence basis for selecting the best second conduit in coronary artery bypass grafting (CABG). We thus aimed to perform head-to-head relative effect estimate on angiographic outcomes for second conduits, including the right internal mammary artery (RIMA), radial artery (RA), right gastroepiploic artery (RGEA) and saphenous vein graft (SVG) by means of network meta-analysis of randomized controlled trials (RCTs). METHODS: Databases were searched for RCTs comparing angiographic outcomes (≥4 weeks) of second conduits in CABG. Odds ratios (95% confidence intervals) were computed with Markov Chain Monte Carlo simulation. RESULTS: A total of nine RCTs were identified, including 2780 patients and 1620 angiographic results available for analysis to compare RIMA (n=145) versus RA (n=871) versus RGEA (n=92) versus SVG (n=845). The mean time to angiographic follow-up ranged from 1 to 7.7 years. An SVG was significantly associated with a 4-fold (1.67-16.00) and 3-fold (0.78-22.20) increased risk of late (≥4 years) functional graft occlusion when compared with the RIMA and RA, respectively. A RIMA was associated with a non-significant 27% absolute risk reduction for functional graft occlusion when compared with the RA. CONCLUSIONS: The present network meta-analysis consistently demonstrated an angiographic superiority of RIMA and RA over SVG. The RIMA is expected to achieve a better patency rate than the RA, but further studies are needed.
OBJECTIVES: There is a lack of unequivocal evidence basis for selecting the best second conduit in coronary artery bypass grafting (CABG). We thus aimed to perform head-to-head relative effect estimate on angiographic outcomes for second conduits, including the right internal mammary artery (RIMA), radial artery (RA), right gastroepiploic artery (RGEA) and saphenous vein graft (SVG) by means of network meta-analysis of randomized controlled trials (RCTs). METHODS: Databases were searched for RCTs comparing angiographic outcomes (≥4 weeks) of second conduits in CABG. Odds ratios (95% confidence intervals) were computed with Markov Chain Monte Carlo simulation. RESULTS: A total of nine RCTs were identified, including 2780 patients and 1620 angiographic results available for analysis to compare RIMA (n=145) versus RA (n=871) versus RGEA (n=92) versus SVG (n=845). The mean time to angiographic follow-up ranged from 1 to 7.7 years. An SVG was significantly associated with a 4-fold (1.67-16.00) and 3-fold (0.78-22.20) increased risk of late (≥4 years) functional graft occlusion when compared with the RIMA and RA, respectively. A RIMA was associated with a non-significant 27% absolute risk reduction for functional graft occlusion when compared with the RA. CONCLUSIONS: The present network meta-analysis consistently demonstrated an angiographic superiority of RIMA and RA over SVG. The RIMA is expected to achieve a better patency rate than the RA, but further studies are needed.
Authors: Mario Gaudino; Umberto Benedetto; Stephen Fremes; Karla Ballman; Giuseppe Biondi-Zoccai; Art Sedrakyan; Giuseppe Nasso; Jai Raman; Brian Buxton; Philip A Hayward; Neil Moat; Peter Collins; Carolyn Webb; Miodrag Peric; Ivana Petrovic; Kyung J Yoo; Irbaz Hameed; Antonino Di Franco; Marco Moscarelli; Giuseppe Speziale; John D Puskas; Leonard N Girardi; David L Hare; David P Taggart Journal: JAMA Date: 2020-07-14 Impact factor: 56.272
Authors: Bassel Mohammad Nijres; Anas S Taqatqa; Lamya Mubayed; Gregory J Jutzy; Ra-Id Abdulla; Karim A Diab; Hoang H Nguyen; Brieann A Muller; Cyndi R Sosnowski; Joshua J Murphy; Joseph Vettukattil; Vishal R Kaley; Darcy N Marckini; Bennett P Samuel; Khaled Abdelhady; Sawsan Awad Journal: Pediatr Cardiol Date: 2018-08-13 Impact factor: 1.655
Authors: Etem Caliskan; Domingos Ramos de Souza; Andreas Böning; Oliver J Liakopoulos; Yeong-Hoon Choi; John Pepper; C Michael Gibson; Louis P Perrault; Randall K Wolf; Ki-Bong Kim; Maximilian Y Emmert Journal: Nat Rev Cardiol Date: 2019-08-27 Impact factor: 32.419